Denka Company Limited, a Tokyo, Japan-based entity founded in 1915, operates internationally as a manufacturer and supplier of a wide array of organic and inorganic materials, electronic components, and pharmaceutical products. Its Electronics & Innovative Products division delivers specialized solutions like conductive agents essential for lithium-ion batteries, advanced thermal management materials, various substrates, high-performance ceramics, and adhesive films and tapes. The Life Innovation segment is dedicated to the production of influenza vaccines, the development of rapid diagnostic test kits for infectious diseases such as the novel coronavirus, and the provision of macromolecular sodium hyaluronate preparations. Within its Elastomers & Infrastructure Solutions division, the company offers functional elastomers, cement and specialized cement additives, agricultural fertilizers, and corrugated piping designed for farming applications. Lastly, the Polymer Solutions division focuses on polymer-based offerings, including styrene resins, sheets used for food packaging, synthetic fibers utilized in wigs and hairpieces, and other chemical compounds like poval. The company, initially incorporated as Denki Kagaku Kogyo Kabushiki Kaisha, officially adopted its current name, Denka Company Limited, in October 2015.
最新数据
JP¥3,283
+JP¥103 · +3.24%
盘中时间采用JST。市场数据可能有所延迟。
Denka Company Limited, a Tokyo, Japan-based entity founded in 1915, operates internationally as a manufacturer and supplier of a wide array of organic and inorganic materials, electronic components, and pharmaceutical products. Its Electronics & Innovative Products division delivers specialized solutions like conductive agents essential for lithium-ion batteries, advanced thermal management materials, various substrates, high-performance ceramics, and adhesive films and tapes. The Life Innovation segment is dedicated to the production of influenza vaccines, the development of rapid diagnostic test kits for infectious diseases such as the novel coronavirus, and the provision of macromolecular sodium hyaluronate preparations. Within its Elastomers & Infrastructure Solutions division, the company offers functional elastomers, cement and specialized cement additives, agricultural fertilizers, and corrugated piping designed for farming applications. Lastly, the Polymer Solutions division focuses on polymer-based offerings, including styrene resins, sheets used for food packaging, synthetic fibers utilized in wigs and hairpieces, and other chemical compounds like poval. The company, initially incorporated as Denki Kagaku Kogyo Kabushiki Kaisha, officially adopted its current name, Denka Company Limited, in October 2015.
日内区间
当前JP¥3,283
52周区间
当前JP¥3,283
盘中时间采用JST。市场数据可能有所延迟。
Denka Company Limited, a Tokyo, Japan-based entity founded in 1915, operates internationally as a manufacturer and supplier of a wide array of organic and inorganic materials, electronic components, and pharmaceutical products. Its Electronics & Innovative Products division delivers specialized solutions like conductive agents essential for lithium-ion batteries, advanced thermal management materials, various substrates, high-performance ceramics, and adhesive films and tapes. The Life Innovation segment is dedicated to the production of influenza vaccines, the development of rapid diagnostic test kits for infectious diseases such as the novel coronavirus, and the provision of macromolecular sodium hyaluronate preparations. Within its Elastomers & Infrastructure Solutions division, the company offers functional elastomers, cement and specialized cement additives, agricultural fertilizers, and corrugated piping designed for farming applications. Lastly, the Polymer Solutions division focuses on polymer-based offerings, including styrene resins, sheets used for food packaging, synthetic fibers utilized in wigs and hairpieces, and other chemical compounds like poval. The company, initially incorporated as Denki Kagaku Kogyo Kabushiki Kaisha, officially adopted its current name, Denka Company Limited, in October 2015.
日内区间
当前JP¥3,283
52周区间
当前JP¥3,283
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(JPY) | 2026财年 | 2025财年 | 2024财年 | 2023财年 | 2022财年 |
|---|---|---|---|---|---|
| 营收 | 3842.47亿 JPY | 4002.51亿 JPY | 3892.63亿 JPY | 4075.59亿 JPY | 3848.49亿 JPY |
| 销货成本 | 2899.91亿 JPY | 3132.13亿 JPY | 3042.8亿 JPY | 3029.71亿 JPY | 2753.9亿 JPY |
| 毛利 | 942.56亿 JPY | 870.38亿 JPY | 849.83亿 JPY | 1045.88亿 JPY | 1094.59亿 JPY |
| 研究与开发 | — | 148.87亿 JPY | 151.62亿 JPY | 149.26亿 JPY | 142.31亿 JPY |
| 销售、一般及管理费用 | 680.3亿 JPY | 577.37亿 JPY | 564.44亿 JPY | 573.37亿 JPY | 551.04亿 JPY |
| 营业费用 | 680.3亿 JPY | 726.24亿 JPY | 716.06亿 JPY | 722.63亿 JPY | 693.35亿 JPY |
| 利息收入 | 3.28亿 JPY | 5.49亿 JPY | 2.15亿 JPY | — | 5800万 JPY |
| 利息支出 | 21.04亿 JPY | 20.93亿 JPY | 16.83亿 JPY | 11.57亿 JPY | 9.24亿 JPY |
| 折旧和摊销 | 291.65亿 JPY | 278.57亿 JPY | 269.19亿 JPY | 270.4亿 JPY | 238.82亿 JPY |
| 营业利润 | 262.26亿 JPY | 144.14亿 JPY | 133.77亿 JPY | 323.25亿 JPY | 401.24亿 JPY |
| 净利润 | 156.95亿 JPY | −123亿 JPY | 119.48亿 JPY | 127.69亿 JPY | 260.12亿 JPY |
公司数据更新于 2026年10月5日。
近期已公布业绩
近期已公布业绩
年度分割调整后的每股现金分配。
JP¥100
2025年(完整年度)-25.9% 自从 2021
2026年(部分年度):JP¥100
JP¥135
2,021
JP¥145
2,022
JP¥90.00
2,023
JP¥90.00
2,024
JP¥100
2,025
JP¥100
2,026*
* 在现有股息历史记录中,该日历年仅包含部分期间。
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息即将实施 | 2027年3月30日 | JP¥50.00Semi-Annual | 2027年3月31日 | 2027年3月30日 |
股息 | 2026年9月29日 | JP¥50.00Semi-Annual | 2026年9月30日 | 2026年9月29日 |
股息 | 2026年3月30日 | JP¥50.00Semi-Annual | 2026年3月31日 | 2026年6月22日 |
股息 | 2025年9月29日 | JP¥50.00Semi-Annual | 2025年9月30日 | 2025年12月2日 |
股息 | 2025年3月28日 | JP¥50.00Semi-Annual | 2025年3月31日 | 2025年6月23日 |
股息 | 2024年9月27日 | JP¥50.00Semi-Annual | 2024年9月30日 | 2024年12月3日 |
除息 2027年3月30日
JP¥50.00
Semi-Annual
2027年3月31日登记 · 支付日 2027年3月30日
除息 2026年9月29日
JP¥50.00
Semi-Annual
2026年9月30日登记 · 支付日 2026年9月29日
除息 2026年3月30日
JP¥50.00
Semi-Annual
2026年3月31日登记 · 支付日 2026年6月22日
除息 2025年9月29日
JP¥50.00
Semi-Annual
2025年9月30日登记 · 支付日 2025年12月2日
除息 2025年3月28日
JP¥50.00
Semi-Annual
2025年3月31日登记 · 支付日 2025年6月23日
除息 2024年9月27日
JP¥50.00
Semi-Annual
2024年9月30日登记 · 支付日 2024年12月3日
报告持有此股票敞口的交易所交易基金。
NEXT FUNDS TOPIX Exchange Traded Fund1306.T78.96亿0.02%35.04万亿 JPY0.05%JP¥436.3+1.42%
Next Funds Nikkei 225 ETF1321.T58.33亿0.03%18.28万亿 JPY0.08%JP¥727.9+2.46%
Nikko Exchange Traded Index Fund 2251330.T28.73亿0.03%8.93万亿 JPY0.08%JP¥72,820+1.97%
iShares Core Nikkei 225 ETF1329.T7.04亿0.03%2.29万亿 JPY0.05%JP¥7,283+2.52%
iShares Core TOPIX ETF1475.T6.8亿0.02%3.04万亿 JPY0.05%JP¥429+1.39%
Avantis International Small Cap Value ETFAVDV3449.82万0.17%202.05亿 USD0.36%US$109.01-0.07%
Vanguard Total International Stock ETFVXUS2500.74万0.00%6657亿 USD0.05%US$85.875+0.52%
Vanguard FTSE Developed Markets ETFVEA1648.74万0.01%3238亿 USD0.03%US$71.165+0.05%
NEXT FUNDS TOPIX Exchange Traded Fund1306.T
Next Funds Nikkei 225 ETF1321.T
Nikko Exchange Traded Index Fund 2251330.T
iShares Core Nikkei 225 ETF1329.T
iShares Core TOPIX ETF1475.T
Avantis International Small Cap Value ETFAVDV
Vanguard Total International Stock ETFVXUS
Vanguard FTSE Developed Markets ETFVEAAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。